About Dr. Peush Bajpai
Dr. Peush Bajpai is a highly distinguished and leading medical oncologist in India, with nearly two decades of rich clinical experience. Dr. Bajpai is a renowned expert in managing Gynaecological and Breast Malignancies, as well as complex Haematological Cancers. He is at the forefront of modern cancer treatment, with a profound interest and expertise in Molecular Oncology, Precision Oncology, Targeted Therapies, and Immunotherapies. Having held leadership positions at top hospitals, his commitment to integrating biomarker-guided therapy with compassionate care makes him one of the top cancer specialists in Delhi for personalised cancer treatment.
OPD Schedule Of Dr. Peush Bajpai
Consultation Fees Rs. 1100 /-
Manipal Hospitals Dwarka, Delhi
Qualifications & Credentials
- DM (Medical Oncology)
- MD (General Medicine)
- MBBS
- Advanced Course (Prostate Cancer): National Cancer Institute, Singapore (2018)
- ESMO Preceptorships: Lung, Gastric, and Prostate Cancers (2012)
- Advanced Course (Tropical Medicine): University of Rostock, Germany (2004)
- Specialist Accreditation in Medical Oncology: European Society of Medical Oncology (ESMO) Certification (2012)
- Certification (Healthcare Management): Indian School of Business (ISB) (2023)
Areas of Expertise
- Breast Cancer
- Gynaecological Cancers (Ovarian, Uterine, Cervical)
- Haematological Malignancies: Lymphoma, Leukaemia (CML, ALL), Multiple Myeloma
- Gastrointestinal Cancers (Colorectal, Gastric, Pancreatic, Hepatobiliary)
- Lung Cancer
- Prostate Cancer
- Soft Tissue Sarcomas
- Medical Oncology
- Breast Oncology (Medical)
- Gynae-Oncology (Medical)
- Hemato-oncology
- Precision and Molecular Oncology
- Immuno-Oncology
- Immunotherapy (including immune checkpoint inhibitors)
- Targeted Therapy (based on molecular markers)
- Precision Medicine: NGS interpretation, biomarker-guided therapy (HRD/TMB/MSI-based)
- Advanced Chemotherapy Regimens
- Hormonal Therapy
List of Disease and Treatment for which Dr. Peush Bajpai can be consulted
Professional Experience
- Current Affiliations: Director & Unit Head - Medical Oncology, Max Hospital, Dwarka, New Delhi
- Past Affiliations:
- HOD – Medical & Hemato-Oncology, Manipal Hospital, Dwarka, New Delhi
- Senior Consultant, Max Super Speciality Hospital, Shalimar Bagh, New Delhi
- Consultant, BLK Super Speciality Hospital, New Delhi
- Senior Registrar/Registrar, Cancer Institute (WIA), Adyar, Chennai
- DM Dissertation Thesis: "Prospective evaluation of musculoskeletal events in patients of CML – chronic phase treated with Imatinib AND possible correlation with electrolyte imbalances".
- MD Dissertation Thesis: "Lifestyle risk factors in Gastro-oesophageal reflux disease".
- Member of prestigious international oncology societies including the American Society of Clinical Oncology (ASCO) and the European Society of Medical Oncology (ESMO).
- Led the comprehensive Breast Cancer Management program at Manipal Hospital, Delhi.
Awards & Recognitions
- First Prize: As part of a team in a Case Presentation at the Indo UK Breast Oncoplasty Masterclass (2016).
- First Prize: In the All India Quiz at the Lymphoma & Leukaemia meet in Mumbai, organised by ESMO (2012).
- Best Poster Award: At BTG Hong Kong for his research on "Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances".
Research & Publications
- Management of Metastatic Colorectal Cancer (mCRC): RealWorld Recommendations (South Asian Journal of Cancer, 2024)
- Collusion: The facade and its implications on total pain management in palliative care (Indian Journal of Palliative Care, 2022)
- Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response (Journal of Gastrointestinal Cancer, 2019)
- Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy (South Asian Journal of Cancer, 2019)
- A rare case of peripheral T-cell lymphoma in one year old child (Indian Journal of Medical and Paediatric Oncology, 2011)
- Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline (Indian Journal of Hematology and Blood Transfusion, 2014)
- Rare case of hairy cell leukemia in a patient of head and neck malignancy (The Tamil Nadu Dr. M.G.R. Medical University, Journal of Medicine, 2012)
Patient Success Stories & Testimonials
- Expert in managing complex and refractory breast and gynaecological cancers using precision medicine and novel drug combinations.
- Successfully treated numerous patients with Chronic Myeloid Leukaemia (CML) and other blood cancers, with a special research focus on managing treatment side effects.
- Pioneered the use of immunotherapy and targeted therapy in real-world settings in India for various solid tumours.
- "Dr. Peush Bajpai is a true expert in breast cancer. He recommended a treatment based on my tumour’s genetic markers, which was far more effective with fewer side effects. His approach is modern, scientific, and deeply reassuring. I am in remission today because of him." - Sunita Sharma
- "My father was diagnosed with advanced lymphoma, and we were fortunate to find Dr. Bajpai. He is not just an amazing doctor but also a great motivator. He won a quiz on lymphoma, and his knowledge truly reflects that. We felt we were in the safest hands." - Ankit Gupta
- "I was diagnosed with ovarian cancer, and Dr. Bajpai handled my case with immense sensitivity and expertise. He is always updated on the latest therapies and made me feel like a partner in my own treatment plan. A truly wonderful and knowledgeable oncologist." - P. Desai
Treatment Approach & Philosophy
Treatment Costs
Treatment / Procedure | Approximate Cost (INR) | Approximate Cost (USD) |
Chemotherapy (per cycle) | ₹35,000 - ₹1,50,000 | $420 - $1,800 |
Targeted Therapy (Monthly) | ₹1,00,000 - ₹4,00,000 | $1,200 - $4,800 |
Immunotherapy (per cycle) | ₹1,50,000 - ₹5,00,000 | $1,800 - $6,000 |